Source: Health Products Regulatory Authority (ZA) Revision Year: 2021 Publisher: Piramal Critical Care (Pty) Ltd, Office 2, Ground Floor, Kiepersol House, Stonemill Office Park, 300 Acacia Road, Darrenwood 2194
SUFENTA 2 mL solution for injection or infusion.
SUFENTA 10 mL solution for injection or infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection or infusion. (For IV or epidural use.) A clear colourless solution. Free from visible foreign material. |
Each mL contains 0,005 mg (5 µg) sufentanil as sufentanil citrate.
Sugar free.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Sufentanil |
Sufentanil is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine. Structurally, sufentanil differs from fentanyl through the addition of a methoxymethyl group on the piperidine ring (which is believed to reduce duration of action), and the replacement of the phenyl ring by thiophene. The main use of this medication is in operating suites and critical care where pain relief is required for a short period of time. It also offers properties of sedation and this makes it a good analgesic component of anesthetic regimen during an operation |
| List of Excipients |
|---|
|
Hydrochloric acid solution (for pH adjustment) |
Cartons containing: 5 × 2 mL and 5 × 10 mL ampoules.
Piramal Critical Care (Pty) Ltd, Office 2, Ground Floor, Kiepersol House, Stonemill Office Park, 300 Acacia Road, Darrenwood 2194
SUFENTA 2 mL: T/2.9/240
SUFENTA 10 mL: T/2.9/241
22 February 1988
| Drug | Countries | |
|---|---|---|
| SUFENTA | Brazil, Finland, France, Tunisia, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
